Polaris Capital Management »

Cytokinetics shares owned by Polaris Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Polaris Capital Management from 13F filings

Historical chart of Polaris Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Polaris Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Polaris Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $23M 267k 85.19

More positions owned by Polaris Capital Management

Popular CommonStock (BPOP)
Jazz Pharmaceuticals CommonStock (JAZZ)
Smurfit Westrock CommonStock (SW)
Linde CommonStock (LIN)
Lantheus Holdings CommonStock (LNTH)
Arrow Electronics CommonStock (ARW)
Cvs Health Corp CommonStock (CVS)
Jpmorgan Chase & Co CommonStock (JPM)
United Therapeutics Corp CommonStock (UTHR)
Slm Corp CommonStock (SLM)
International Bancshares Corp CommonStock (IBOC)
Marathon Petroleum Corp CommonStock (MPC)
Eastman Chemical CommonStock (EMN)
Cytokinetics CommonStock (CYTK)
Ingredion CommonStock (INGR)

View all positions for Polaris Capital Management

Top funds holding Cytokinetics

BlackRock
Wellington Management Company
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
venBio Select Advisor
Bank of America Corporation
Susquehanna International
Geode Capital Management
Rtw Investments
Armistice Capital
Polar Capital Holdings
Citadel Advisors
Goldman Sachs Group

View all funds holding Cytokinetics